(Q36686826)

15 August 2017

1 reference

title

Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer (English)

1 reference

15 August 2017

1 reference

Catherine J Lee

1

1 reference

15 August 2017

Edgardo V Ariztia

series ordinal

2

1 reference

15 August 2017

David A Fishman

series ordinal

3

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Critical Reviews in Clinical Laboratory Sciences

15 August 2017

published in

1 reference

15 August 2017

volume

44

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

87-114

1 reference

The tumor microenvironment: key to early detection

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

A proteomic approach to characterize protein shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Analysis of albumin-associated peptides and proteins from ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Serum proteomic patterns for detection of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic applications for the early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic approaches in cancer risk and response assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomics: the next revolution in laboratory medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomics of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Discovery and development of biomarkers of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Progress and challenges in screening for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Future for ovarian cancer screening: novel markers from emerging technologies of transcriptional profiling and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Expanded human tissue kallikrein family--a novel panel of cancer biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Localization of mesothelin in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Significance of inhibin in reproductive pathophysiology and current clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Blood and urine markers for ovarian cancer: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Multiplexed particle-based flow cytometric assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Potential markers that complement expression of CA125 in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Unique gene expression profile based on pathologic response in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Clinical proteomics and biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic profiling of pancreatic cancer for biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Laser capture microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Laser capture microdissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Clinical proteomics: Applications for prostate cancer biomarker discovery and detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

General keynote: proteomic patterns in sera serve as biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Monitoring the serological proteome: the latest modality in prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomics in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Laser capture microdissection and advanced molecular analysis of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

An optimized strategy for ICAT quantification of membrane proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Mass spectrometric-based approaches in quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Use of proteomic patterns in serum to identify ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

A high‐performance matrix‐assisted laser desorption/ionization orthogonal time‐of‐flight mass spectrometer with collisional cooling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Applications of a matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometer. l. Metastable decay and collision-induced dissociation for sequencing peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Rapid identification using pyrolysis mass spectrometry and artificial neural networks of Propionibacterium acnes isolated from dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

High-resolution serum proteomic features for ovarian cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Clinical proteomics: Written in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Biomarker amplification by serum carrier protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Characterization of the low molecular weight human serum proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

An investigation into the human serum "interactome"

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Putative protein markers in the sera of men with prostatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Recent developments in biomarkers for the early detection of lung cancer: perspectives based on publications 2003 to present

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

An overview of lung cancer genomics and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Diagnostic potential in bladder cancer of a panel of tumor markers (calreticulin, gamma -synuclein, and catechol-o-methyltransferase) identified by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic technologies and their application to pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Protein microarrays: molecular profiling technologies for clinical specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Molecular profiling of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Signal pathway profiling of ovarian cancer from human tissue specimens using reverse‐phase protein microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identificati

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Limitations of current proteomics technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Detection technologies in proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Two-dimensional gel electrophoresis; better than a poke in the ICAT?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Shotgun proteomics and biomarker discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408360600778885

10.1080/10408360600778885

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference